Pneumococcal pneumonia in adults – Re-emergence of vaccine serotypes: a prospective multicentre cohort study in Germany, 2020-2023
Escrito por Christina Bahrs, Norman Rose, Grit Barten-Neiner, Carolin Fleischmann-Struzek, Mark P. G. van der Linden, Gernot Rohde, Jan Rupp, Martin Witzenrath, Jessica Rademacher y Mathias W. Pletz
Publicada
Servidor
medRxiv
DOI
10.1101/2025.10.24.25338303
This prospective multicentre study investigated pneumococcal serotype distribution and vaccine coverage of the 13- and 20-valent conjugate vaccines, and the 23-valent polysaccharide vaccine among adults with community-acquired pneumonia in Germany, from 2020 to 2023, using serotype-specific urine antigen detection testing. The findings show that Streptococcus pneumoniae has reemerged as causative pathogen of pneumonia, particularly in adults aged ≥60 years. This resurgence, observed during the ongoing SARS-CoV-2 pandemic, has been primarily driven by an increase in cases due to serotype 3.
Puedes escribir una PREreview de Pneumococcal pneumonia in adults – Re-emergence of vaccine serotypes: a prospective multicentre cohort study in Germany, 2020-2023. Una PREreview es una revisión de un preprint y puede variar desde unas pocas oraciones hasta un extenso informe, similar a un informe de revisión por pares organizado por una revista.
Antes de comenzar
Te pediremos que inicies sesión con tu ORCID iD. Si no tienes un iD, puedes crear uno.
¿Qué es un ORCID iD?
Un ORCID iD es un identificador único que te distingue de otros/as con tu mismo nombre o uno similar.